Andrew J. Gunderson, Ph.D.
Affiliations: | 2012 | Pennsylvania State University, State College, PA, United States |
Area:
Immunology, Cell Biology, OncologyGoogle:
"Andrew Gunderson"Parents
Sign in to add mentor| Adam B. Glick | grad student | 2012 | Penn State | |
| (The tumor promoting roles of lymphocytes during RAS initiated inflammation and skin carcinogenesis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Khanal S, Wieland A, Gunderson AJ. (2023) Mechanisms of tertiary lymphoid structure formation: cooperation between inflammation and antigenicity. Frontiers in Immunology. 14: 1267654 |
| Medler TR, Kramer G, Bambina S, et al. (2023) Tumor resident memory CD8 T cells and concomitant tumor immunity develop independently of CD4 help. Scientific Reports. 13: 6277 |
| Zheng C, Fass JN, Shih YP, et al. (2022) Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancers. Cancer Cell. 40: 410-423.e7 |
| Bernard B, Rajamanickam V, Dubay C, et al. (2020) Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancer. Plos One. 15: e0238380 |
| Gunderson AJ, Yamazaki T, McCarty K, et al. (2020) TGFβ suppresses CD8 T cell expression of CXCR3 and tumor trafficking. Nature Communications. 11: 1749 |
| Gunderson AJ, Yamazaki T, McCarty K, et al. (2019) Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma. Plos One. 14: e0211117 |
| Gunderson A, Yamazaki T, McCarty K, et al. (2019) TGFβR1 Antagonism Improves Radiation Efficacy By Relieving CXCR3 Suppression and Enhancing Tumor Recruitment of CD8+ T Cells International Journal of Radiation Oncology*Biology*Physics. 105: S87-S88 |
| Elhalawani H, He R, Yamazaki T, et al. (2019) Multiparametric MRI Measures Correlate with Treatment Response and CD8 T Cell Infiltrate in Phase II Study of Tgfβri Inhibitor with Chemoradiation in Locally Advanced Rectal Cancer International Journal of Radiation Oncology*Biology*Physics. 105: S58-S59 |
| Podolsky MA, Bailey JT, Gunderson AJ, et al. (2017) Differentiated state of initiating tumor cells is key to distinctive immune responses seen in H-RasG12V-induced squamous tumors. Cancer Immunology Research |
| Glick AB, Bailey JT, Gunderson A, et al. (2017) Abstract 2673: Divergent therapeutic responses to CD40L blockade or CD40 activation in Ras-driven skin cancers determined by origin of tumor initiating cell Cancer Research. 77: 2673-2673 |